EAGLE BIOLOGICS INC has a total of 51 patent applications. It increased the IP activity by 150.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, Australia and Japan. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are ARSIA THERAPEUTICS INC, ADC THERAPEUTICS S RL and NORDIC NANOVECTOR ASA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | Australia | 8 | |
#3 | Japan | 6 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | Hong Kong | 5 | |
#6 | Singapore | 5 | |
#7 | Israel | 4 | |
#8 | China | 3 | |
#9 | Canada | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Operating tables | |
#5 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Langer Robert S | 43 |
#2 | Crane Alan | 40 |
#3 | Love Kevin | 40 |
#4 | Weight Alisha K | 36 |
#5 | Larson Alyssa M | 36 |
#6 | Klibanov Alexander M | 36 |
#7 | Alan Crane | 7 |
#8 | Alexander M Klibanov | 7 |
#9 | Kevin Love | 7 |
#10 | Alisha K Weight | 7 |
Publication | Filing date | Title |
---|---|---|
MX2017004306A | Polysaccharide and nucleic acid formulations containing viscosity-lowering agents. |